Key Market Indicators
Finland's insulin imports are projected to climb to approximately $85.5 million by 2028, a modest increase from around $83.1 million in 2023. This represents an average annual growth rate of 0.3%. The country's demand for insulin has shown a steady rise, averaging a 0.7% increase each year since 1993. In stark contrast, Finland's insulin exports saw a dramatic decline. In 2018, exports plummeted to about $202,000, a staggering drop of nearly 96% from the previous year's figure of roughly $4.9 million. This significant reduction in exports highlights a shifting dynamic in Finland's insulin market, suggesting potential challenges or changes in the country's production and distribution capabilities.
